Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Feb 23, 2015

30339_dirs_2015-02-23_e9adabc7-993b-4209-ace1-0e7a9e5afef3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-17

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-17 Common Stock A 3578.0000 $51.5300 Acquired 71168.0700 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 908.3538 Indirect
Common Stock 7302.7700 Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2012 that have vested for performance period 11.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.